These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Gynecol Oncol; 2006 Jan 15; 100(1):58-64. PubMed ID: 16137750 [Abstract] [Full Text] [Related]
13. Risk of endometrial carcinoma associated with BRCA mutation. Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J. Gynecol Oncol; 2001 Mar 15; 80(3):395-8. PubMed ID: 11263938 [Abstract] [Full Text] [Related]
15. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation. Piek JM, Dorsman JC, Massuger LF, Ansink AC, Weegenaar J, Shvarts A, Kenemans P, Verheijen RH. Arch Gynecol Obstet; 2006 Oct 15; 274(6):327-31. PubMed ID: 16826413 [Abstract] [Full Text] [Related]
16. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ. Am J Surg Pathol; 2009 Jan 15; 33(1):111-9. PubMed ID: 18830124 [Abstract] [Full Text] [Related]
18. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group. J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670 [Abstract] [Full Text] [Related]